Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial
2014 · The Lancet Oncology · 409 citations
https://doi.org/10.1016/s1470-2045(14)70212-8
P
Pascale Cervera
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
117
Papers
6.1K
Citations
35
h-index
57
i10-index
Pascale Cervera is an academic researcher from Inserm. The author has contributed to research in topics: Genetic factors in colorectal cancer & Colorectal Cancer Treatments and Studies & Nuclear Structure and Function. The author has an h-index of 35, co-authored 100 publications.
ORCID: 0000-0001-6048-2214Papers by this author
worksAltered Fat Differentiation and Adipocytokine Expression are Inter-Related and Linked to Morphological Changes and Insulin Resistance in HIV-1-Infected Lipodystrophic Patients
2004 · Antiviral Therapy · 171 citations
https://doi.org/10.1177/135965350400900412
Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instability
2023 · Annals of Oncology · 43 citations
https://doi.org/10.1016/j.annonc.2023.05.010
Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR study
2013 · Annals of Oncology · 42 citations
https://doi.org/10.1093/annonc/mdt393
Familial Adenomatous Polyposis-Associated Desmoids Display Significantly More Genetic Changes than Sporadic Desmoids
2011 · PLoS ONE · 26 citations
https://doi.org/10.1371/journal.pone.0024354
HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)
2022 · AIDS Research and Therapy · 3 citations
https://doi.org/10.1186/s12981-022-00440-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat